Sol-Gel Technologies Ltd. (SLGL)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Sol-Gel Technologies Ltd. (SLGL)
Go deeper and ask any question about SLGL
Company Performance
Current Price
as of Sep 13, 2024$0.62
P/E Ratio
N/A
Market Cap
$17.27M
Description
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Metrics
Overview
- HQNess Ziona, TA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerSLGL
- Price$0.62-1.59%
Trading Information
- Market Cap$17.27M
- Float33.80%
- Average Daily Volume (1m)211,177
- Average Daily Volume (3m)395,689
- EPS-$0.54
Company
- Revenue$6.56M
- Rev Growth (1yr)814.65%
- Net Income$1.98M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDAN/A
- EV-$4.29M
- EV/Revenue-0.65
- P/EN/A
- P/S2.63